Yale University researchers have determined how a scarce molecule produced by marine bacteria can kill cancer cells, paving the way for the development of new, low-dose chemotherapies.The molecule, lomaiviticin A, was previously shown to be lethal to...
The National Institutes of Health (NIH) has awarded Yale chemist Jason Crawford a five-year, $2.5 million grant that will support his study of gut-dwelling bacteria that play a role in the development of colorectal cancer.Jason CrawfordCrawford, who...
Scientists have developed a new approach for treating a deadly brain cancer that strikes 15,000 in the United States annually and for which there is no effective long-term therapy. The researchers, from Yale and Johns Hopkins, have shown that the approach...